J9229 – Injection, inotuzumab ozogamicin, 0.1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9229
- Long description
- Injection, inotuzumab ozogamicin, 0.1 mg
- Short description
- Inj inotuzumab ozogam 0.1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2019
- Last change
- January 1, 2019 – No change
Frequently asked questions
What is HCPCS code J9229?
J9229 is a HCPCS Level II code for injection, inotuzumab ozogamicin, 0.1 mg.
Does Medicare cover J9229?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9218 – Leuprolide acetate, per 1 mg
- J9219 – Leuprolide acetate implant, 65 mg
- J9220 – Injection, indigotindisulfonate sodium, 1 mg
- J9223 – Injection, lurbinectedin, 0.1 mg
- J9225 – Histrelin implant (vantas), 50 mg
- J9226 – Histrelin implant (supprelin la), 50 mg
- J9227 – Injection, isatuximab-irfc, 10 mg
- J9228 – Injection, ipilimumab, 1 mg
- J9230 – Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
- J9232 – Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg
- J9245 – Injection, melphalan hydrochloride, not otherwise specified, 50 mg
- J9246 – Injection, melphalan (evomela), 1 mg
- J9247 – Injection, melphalan flufenamide, 1mg
- J9248 – Injection, melphalan (hepzato), 1 mg
- J9249 – Injection, melphalan (apotex), 1 mg
- J9250 – Methotrexate sodium, 5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.